$3.44
0.44%
Nasdaq, Oct 02, 04:00 pm EDT. Closed.
ISIN
CA35954B2066
Symbol
QNTM

FSD Pharma Inc Stock price

$3.44
+0.36 11.69% 1M
-0.54 13.57% 6M
-3.86 52.88% YTD
-14.66 80.99% 1Y
-71.96 95.44% 3Y
-92.11 96.40% 5Y
-1,122.76 99.69% 10Y
-1,122.76 99.69% 20Y
Nasdaq, Closing price Fri, Oct 02 2026
+0.02 0.44%
ISIN
CA35954B2066
Symbol
QNTM
Industry

Is FSD Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
$31.3m
Enterprise Value
$22.5m
Net debt
positive
Cash
$9.8m
Shares outstanding
7.6m
Valuation
P/E
negative
P/S | estimate
- | 5.2
EV/Sales | estimate
- | 5.1
EV/FCF | ex SBC
negative | negative
P/B
3.9
Financial Health
Equity Ratio
-
Return on Equity
-
ROCE
-202.2%
ROIC
-
Debt/Equity
0.1
Share-Based Compensation & Dilution
SBC | % of Revenue
$2.7m | -
SBC as % of FCF
-
SBC Growth 1Y
142.0%
Share Count Growth 1Y
118.4%
Shareholder Yield
-118.4%
Financials
Revenue | estimate
$0.0 | $15.0m
EBITDA
$-11.8m
EBIT
$-12.3m
Net Income
$-25.2m
Free Cash Flow | ex SBC
$-5.5m | $-8.2m
Growth
Revenue | estimate
- | -
EBITDA
35.2%
EBIT
34.1%
Net Income
5.4%
Free Cash Flow
47.8%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow | ex SBC
- | -
More
EPS
$-3.8
FCF per Share
$-0.7
Short interest
3.2%
Employees
-
Rev per Employee
-

FSD Pharma Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a FSD Pharma Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a FSD Pharma Inc forecast:

Buy
86%
Hold
14%

Financial data from FSD Pharma Inc

Jun '26
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 10 10
7% 7%
-
- Research and Development Expense 1.58 1.58
78% 78%
-
-12 -12
35% 35%
-
- Depreciation and Amortization 0.53 0.53
6% 6%
-
EBIT (Operating Income) EBIT -12 -12
34% 34%
-
Net Profit -25 -25
5% 5%
-

In millions USD.

Don't miss a Thing! We will send you all news about FSD Pharma Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

FSD Pharma Inc Stock News

Neutral
GlobeNewsWire
●
10 days ago
TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd.
Neutral
GlobeNewsWire
●
17 days ago
TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd.
Neutral
GlobeNewsWire
●
20 days ago
AUSTIN, Texas, Sept. 14, 2026 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach,” featuring Quantum BioPharma Ltd . (NASDAQ: QNTM).
More FSD Pharma Inc News

Company Profile

FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. FSD Pharma Inc. has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products; and collaborative research and development agreement with Solarvest BioEnergy Inc. The company is headquartered in Cobourg, Canada.

Head office Canada
CEO Mr. Saeed
Founded 1994
Website www.quantumbiopharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today